Long | ATOS | This is a rare opportunity

ATOS

1- It's at support level right now, consolidated for 2 weeks.
2- It had a direct offering of 50m$ 2 weeks ago, new Institutional investors joined the team, they already had public offering and they didn't need any cash, they have cash for 3-4 years of operational cost.
3- it has 2 products for waiting P2 approval, one if them halted in Feb, because the results were great but didn't published the official approval from FDA yet, (Expected in 2 weeks)
4- it has a cure for cancer, put money in this company is a good cause and RIO is insane,
5- Average of price target is 6.25$, it means 300% .
6- buy-out is one of the possible options, and I expect an average price of 11$, it should be happen before shareholder meeting (less than 2 month)

* these are my ideas and could be wrong 100%, but if it be right thanks me later. lol